| 36.3 |
108.9 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 21.8 |
196.1 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 21.3 |
106.5 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 18.8 |
113.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 17.3 |
104.0 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 16.8 |
50.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 16.7 |
83.7 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 16.3 |
65.4 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 15.7 |
78.7 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 15.0 |
164.9 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 14.8 |
74.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 14.1 |
126.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 13.5 |
108.3 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 12.0 |
59.9 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 11.8 |
70.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 11.5 |
57.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 11.1 |
44.4 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 10.5 |
73.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 9.8 |
29.4 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 9.6 |
28.8 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 9.6 |
38.3 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 9.5 |
143.1 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 9.1 |
36.6 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 8.7 |
34.7 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 8.4 |
25.2 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 8.4 |
41.9 |
GO:0032763 |
regulation of mast cell cytokine production(GO:0032763) |
| 8.4 |
108.9 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 8.4 |
25.1 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 7.9 |
7.9 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 7.7 |
30.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 7.5 |
22.6 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 7.5 |
90.1 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 7.4 |
66.6 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 7.2 |
21.7 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 7.1 |
297.0 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 7.0 |
49.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 7.0 |
42.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 6.9 |
90.2 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
| 6.9 |
20.7 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 6.9 |
34.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 6.8 |
34.1 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 6.8 |
34.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 6.8 |
27.3 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 6.8 |
13.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 6.6 |
52.8 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 6.6 |
26.3 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 6.3 |
62.6 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 6.1 |
79.6 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 5.9 |
106.4 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 5.7 |
178.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 5.6 |
27.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 5.5 |
177.3 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 5.5 |
32.8 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 5.4 |
16.3 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 5.4 |
21.5 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 5.2 |
21.0 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) negative regulation of action potential(GO:0045759) |
| 5.1 |
41.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 5.1 |
101.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 4.8 |
14.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 4.8 |
19.2 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 4.8 |
14.4 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 4.6 |
54.9 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 4.6 |
31.9 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 4.6 |
45.6 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 4.5 |
58.9 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 4.5 |
31.4 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 4.4 |
17.8 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 4.4 |
13.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 4.4 |
17.4 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 4.3 |
12.8 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 4.2 |
12.7 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 4.1 |
8.3 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 4.1 |
24.6 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 4.1 |
24.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 4.0 |
56.1 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 3.9 |
55.3 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 3.9 |
15.8 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 3.9 |
27.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 3.9 |
30.9 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 3.8 |
15.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 3.8 |
11.4 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 3.8 |
15.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 3.7 |
44.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 3.6 |
10.9 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 3.6 |
18.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 3.5 |
24.5 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 3.4 |
6.9 |
GO:0061055 |
myotome development(GO:0061055) |
| 3.4 |
6.8 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 3.4 |
27.3 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 3.4 |
17.0 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 3.4 |
34.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 3.4 |
6.8 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 3.4 |
6.8 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 3.2 |
13.0 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 3.2 |
12.9 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 3.2 |
19.0 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 3.2 |
25.2 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 3.1 |
53.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 3.1 |
15.6 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 3.1 |
24.8 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 3.1 |
55.6 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 3.1 |
15.4 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 3.1 |
9.2 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 3.1 |
70.4 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 3.0 |
42.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 3.0 |
15.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 3.0 |
11.9 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 3.0 |
20.7 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 3.0 |
14.8 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 3.0 |
44.3 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 2.8 |
31.0 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 2.7 |
8.1 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.6 |
28.8 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 2.6 |
176.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 2.6 |
38.8 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 2.6 |
12.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 2.5 |
15.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 2.5 |
38.0 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 2.5 |
7.5 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 2.5 |
9.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 2.5 |
44.2 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 2.4 |
11.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.4 |
7.1 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 2.4 |
4.7 |
GO:1903008 |
organelle disassembly(GO:1903008) |
| 2.4 |
30.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 2.3 |
9.2 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 2.3 |
6.9 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 2.3 |
11.5 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 2.3 |
23.0 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 2.3 |
4.6 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 2.3 |
13.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 2.3 |
6.8 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 2.3 |
88.5 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 2.3 |
20.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 2.2 |
39.9 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 2.1 |
6.4 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 2.1 |
6.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 2.1 |
39.8 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 2.1 |
92.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 2.1 |
16.7 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 2.0 |
16.3 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 2.0 |
6.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 1.9 |
7.8 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 1.8 |
16.5 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 1.8 |
10.9 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 1.8 |
5.4 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 1.8 |
8.9 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 1.8 |
8.9 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 1.8 |
3.5 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 1.7 |
15.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 1.7 |
10.4 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.7 |
5.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 1.7 |
10.0 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.7 |
58.2 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 1.7 |
102.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.7 |
18.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 1.6 |
4.9 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 1.6 |
9.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 1.6 |
6.3 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.6 |
11.0 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 1.6 |
4.7 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.5 |
3.1 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 1.5 |
121.4 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 1.5 |
4.5 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 1.5 |
6.0 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 1.5 |
10.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.5 |
13.4 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 1.5 |
10.4 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 1.5 |
1.5 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 1.4 |
2.9 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 1.4 |
14.4 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 1.4 |
8.6 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 1.4 |
28.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 1.4 |
5.7 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.4 |
19.7 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 1.4 |
7.0 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 1.4 |
4.2 |
GO:2000822 |
regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
| 1.4 |
4.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.4 |
58.0 |
GO:0008542 |
visual learning(GO:0008542) |
| 1.3 |
6.7 |
GO:0036438 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) maintenance of lens transparency(GO:0036438) |
| 1.3 |
7.9 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 1.3 |
6.5 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 1.3 |
119.4 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 1.3 |
7.6 |
GO:0060613 |
fat pad development(GO:0060613) |
| 1.2 |
7.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.2 |
9.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 1.2 |
3.5 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 1.2 |
2.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 1.1 |
6.9 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 1.1 |
4.5 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 1.1 |
5.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 1.1 |
6.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 1.1 |
15.1 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 1.1 |
5.4 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.1 |
2.1 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 1.1 |
4.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.1 |
8.4 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 1.0 |
11.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 1.0 |
3.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 1.0 |
7.3 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 1.0 |
6.2 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 1.0 |
2.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.0 |
9.2 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 1.0 |
31.7 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 1.0 |
11.2 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 1.0 |
10.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 1.0 |
6.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 1.0 |
4.0 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 1.0 |
22.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 1.0 |
3.0 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 1.0 |
3.0 |
GO:0010881 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 1.0 |
29.5 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 1.0 |
52.1 |
GO:0048675 |
axon extension(GO:0048675) |
| 1.0 |
2.9 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 1.0 |
12.5 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.9 |
5.7 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.9 |
3.8 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.9 |
24.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.9 |
2.7 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.9 |
13.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.9 |
3.5 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.9 |
6.9 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.8 |
16.8 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.8 |
10.0 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.8 |
6.6 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.8 |
0.8 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.8 |
4.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.8 |
3.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.8 |
3.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.8 |
7.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.8 |
13.7 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.8 |
6.4 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.8 |
1.6 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
| 0.8 |
6.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.8 |
3.9 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.8 |
4.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.8 |
61.6 |
GO:0021549 |
cerebellum development(GO:0021549) |
| 0.8 |
7.6 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.8 |
8.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.7 |
3.0 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.7 |
2.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.7 |
7.3 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.7 |
2.9 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.7 |
3.6 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.7 |
47.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.7 |
3.5 |
GO:0060467 |
regulation of acrosome reaction(GO:0060046) negative regulation of fertilization(GO:0060467) |
| 0.7 |
8.4 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.7 |
6.2 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.7 |
16.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.7 |
8.1 |
GO:0042036 |
negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.7 |
8.0 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
| 0.7 |
2.0 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.7 |
17.6 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.6 |
6.4 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.6 |
5.8 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.6 |
5.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.6 |
2.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.6 |
41.0 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.6 |
29.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.6 |
17.0 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.6 |
2.5 |
GO:0021548 |
pons development(GO:0021548) cochlear nucleus development(GO:0021747) cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.6 |
1.9 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.6 |
5.0 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.6 |
10.0 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 |
11.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.6 |
9.1 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.6 |
2.4 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.6 |
15.5 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.6 |
4.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.6 |
3.4 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.6 |
1.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.6 |
1.1 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.6 |
2.8 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.6 |
3.9 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.6 |
1.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.6 |
5.5 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.6 |
2.2 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.5 |
3.8 |
GO:0019800 |
peptide cross-linking(GO:0018149) peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 |
29.2 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.5 |
6.9 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.5 |
2.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.5 |
5.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.5 |
3.7 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.5 |
1.0 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.5 |
13.0 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
6.7 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.5 |
1.5 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.5 |
12.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.5 |
1.9 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.5 |
2.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.5 |
2.8 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.5 |
0.9 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.5 |
8.7 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.5 |
3.2 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.5 |
2.3 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.4 |
22.8 |
GO:0007612 |
learning(GO:0007612) |
| 0.4 |
4.0 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.4 |
1.3 |
GO:0060126 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) somatotropin secreting cell differentiation(GO:0060126) |
| 0.4 |
2.2 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.4 |
0.9 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.4 |
2.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.4 |
3.5 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.4 |
2.1 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.4 |
3.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.4 |
2.1 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.4 |
12.3 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.4 |
4.1 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.4 |
4.1 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.4 |
2.8 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.4 |
4.8 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.4 |
3.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 |
4.7 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.4 |
6.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.4 |
4.9 |
GO:0032402 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.4 |
3.7 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.4 |
0.4 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.4 |
2.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.3 |
1.4 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.3 |
2.4 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.3 |
2.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.3 |
2.0 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
2.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.3 |
1.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.3 |
5.5 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.3 |
1.2 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.3 |
3.2 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.3 |
4.7 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.3 |
2.0 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.3 |
0.9 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.3 |
5.7 |
GO:1990138 |
neuron projection extension(GO:1990138) |
| 0.3 |
4.6 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.3 |
1.4 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.3 |
3.4 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.3 |
2.5 |
GO:0060004 |
reflex(GO:0060004) |
| 0.3 |
0.3 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.3 |
3.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 |
3.5 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 |
3.6 |
GO:0032094 |
response to food(GO:0032094) |
| 0.3 |
0.8 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.3 |
1.8 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
1.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.2 |
1.7 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
1.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.2 |
8.8 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.2 |
3.9 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.2 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.2 |
3.3 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.2 |
0.7 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.2 |
4.6 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 |
3.9 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
10.5 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.2 |
2.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
1.7 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
6.8 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.2 |
1.8 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
0.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.2 |
4.2 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.2 |
1.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.2 |
5.9 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.2 |
0.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
1.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
4.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
6.3 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.2 |
2.7 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
5.4 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
0.9 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
7.8 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.2 |
1.6 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
1.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 |
1.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
4.3 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.2 |
1.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
4.8 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.2 |
1.1 |
GO:0061088 |
Golgi to endosome transport(GO:0006895) sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
2.2 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
9.5 |
GO:0031929 |
TOR signaling(GO:0031929) |
| 0.1 |
1.7 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.1 |
1.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
1.7 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) |
| 0.1 |
2.1 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.1 |
2.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
1.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
1.0 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
1.1 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
1.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
8.5 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.1 |
0.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.5 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.1 |
5.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.6 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
2.1 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.1 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
6.0 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.1 |
1.9 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
2.3 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
7.9 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.1 |
0.2 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
| 0.1 |
2.7 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.3 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.1 |
2.5 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.5 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
5.3 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
5.2 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.0 |
0.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
2.2 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.0 |
0.2 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
1.7 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.0 |
0.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
1.6 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.5 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.7 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.2 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
